Skip to content
Cyclodextrin News

Cyclodextrin News

A forum for researchers, students and applicants in the field of cyclodextrin technology

  • Home
  • Pharma applications
  • Non-pharma applications
  • CD derivatives
  • Events
  • E-ducation

Tag: Cancer therapy

July 31, 2024 Drug delivery / Pharma applications / Supramolecular systems

Stabilized, ROS-sensitive β-cyclodextrin-grafted hyaluronic supramolecular nanocontainers for CD44-targeted anticancer drug delivery

Hyaluronic acid (HA)-based tumor microenvironment-responsive nanocontainers are attractive candidates for anticancer drug delivery due to HA’s excellent biocompatibility, biodegradability, and

Continue reading

July 26, 2024 CD derivatives / Drug delivery / Pharma applications

Codelivery of Doxorubicin and p53 Gene by β-Cyclodextrin-Based Supramolecular Nanoparticles

A supramolecular system was developed for codelivery of doxorubicin (Dox) and p53 gene based on a β-CD-containing star-shaped cationic polymer.

Continue reading

July 1, 2024 Drug delivery / Pharma applications

Ferroptosis in Cancer Therapy: Mechanisms, Small Molecule Inducers, and Novel Approaches

Ferroptosis, a unique form of programmed cell death, is initiated by an excess of iron accumulation and lipid peroxidation-induced damage.

Continue reading

June 14, 2024 Drug delivery / Pharma applications

Does Vinblastine Retain its Anticancer Effect in the Presence of Cyclodextrin? A Preliminary Study

In this work, investigating the synthesis and characteristics of cyclodextrin-vinblastine compositions, derivatives of the electroneutral DIMEB and the polyanionic SBECD

Continue reading

May 14, 2024 Drug delivery / Pharma applications

Reprogramming of lipid metabolism in the tumor microenvironment: a strategy for tumor immunotherapy

Lipid metabolism in cancer cells has garnered increasing attention in recent decades. Cancer cells thrive in hypoxic conditions, nutrient deficiency,

Continue reading

May 7, 2024 Drug delivery / Pharma applications

Regulating Tumor-Associated Macrophage Polarization by Cyclodextrin-Modified PLGA Nanoparticles Loaded with R848 for Treating Colon Cancer

This study aimed to develop a novel and feasible modification strategy to improve the solubility and antitumor activity of resiquimod

Continue reading

March 18, 2024 CD as API / Drug delivery / Pharma applications

Advances in Ferroptosis-Inducing Agents by Targeted Delivery System in Cancer Therapy

Ferroptosis is a regulated cell death process caused by lipid peroxidation of membrane unsaturated fatty acids catalyzed by iron ions

Continue reading

February 29, 2024 Drug delivery / Pharma applications

Zinc Diethyldithiocarbamate–Cyclodextrin Inclusion Complexes for Potential Lung Cancer Treatment

Zinc diethyldithiocarbamate (Zn (DDC)2), a disulfiram metabolite (anti-alcoholism drug), has shown a strong anti-cancer activity in vitro. However, its application

Continue reading

February 28, 2024 Drug delivery / Pharma applications

Antinociceptive Effect of a p-Cymene/β-Cyclodextrin Inclusion Complex in a Murine Cancer Pain Model

Pain is one of the most prevalent and difficult to manage symptoms in cancer patients, and conventional drugs present a

Continue reading

February 9, 2024 Events / Pharma applications

16th Annual World Cancer Congress (WCC2024-Ireland)

16th Annual World Cancer Congress (WCC2024-Ireland) will be held from October 16-18, 2024 in Dublin, Ireland. I. Introduction of WCC2024-Ireland

Continue reading

Posts pagination

«Previous Posts 1 2 3 4 5 6 … 9 Next Posts»

Recent Posts

  • Cyclodextrin Produced In situ: Rethinking Oat Milk Design for Better Performance
  • Structural diversity of cyclodextrin metal-organic frameworks enables their diverse applications
  • Exploring Cyclodextrin-Based MOFs for Drug Delivery: Synthesis, Applications, and Future Perspectives
  • Sugammadex analog water soluble BCD polymer for peptide complexes
  • 2 nd International Conference on Biomedical Science and Engineering

Tags

alpha-CD atherosclerosis Cancer therapy Captisol Cholesterol Clinical trial conference Covid-19 cyclodextrin polymer Dexolve drug delivery drug delivery systems electrospinning FDA Food gamma-CD Gilead HPBCD hydrogel methyl BCD Nanoparticles Niemann Pick Disease RAMEB remdesivir review SBECD Special issue Sugammadex Synthesis

Follow Us

  • LinkedIn
  • X
  • Facebook

Categories

  • Agriculture (26)
  • Analysis (64)
  • CD as API (343)
  • CD derivatives (404)
  • Cosmetics and toilettry (49)
  • Diagnosis (12)
  • Drug delivery (786)
  • E-ducation (63)
  • Environmental (133)
  • Events (233)
  • Food (221)
  • Gene delivery (20)
  • Household products (4)
  • Household products (1)
  • In Hungarian (4)
  • Life sciences (42)
  • Non-pharma applications (396)
  • Other industrial use (104)
  • Pharma applications (1,173)
  • Supramolecular systems (40)
  • Uncategorized (144)

Top Posts

  • Cyclodextrin Produced In situ: Rethinking Oat Milk Design for Better Performance
  • Structural diversity of cyclodextrin metal-organic frameworks enables their diverse applications
  • Cyclodextrin-based formulations for pediatric patients: pharmaceutical prospectives and toxicological evaluation
  • Lanosterol eye drops for cataract treatment
  • Practical Considerations about the Cyclodextrin Solubilities – A Quickstart Guide for Newbies
  • FDA Grants Approval to HPBCD-Enhanced Biologic: A 'Super-Originator' Formulation
  • Antiepileptic drug with betadex sulfobutyl ether sodium, Fycompa® injection approved in Japan
  • "Advances in Functional Materials" International Conference, 2021
  • Alterations in Proteostasis Mechanisms in Niemann–Pick Type C Disease
  • Aequus and reVision to Collaborate on Stargardt Disease Program using SBECD as active

Subscribe to Blog via Email

Enter your email address to subscribe to this blog and receive notifications of new posts by email.

Join 3,791 other subscribers

Loading Comments...